Medtech grants in the United States
Explore Medtech grants for companies in the United States. This list brings together funding for medical devices, diagnostics, digital health and clinical validation from US innovation agencies, research funders and foundations, international programs open to applicants in the United States, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Medtech in the United States come first.
Showing 49-72 of 938 grants
NHLBI Clinical Trial Pilot Studies
🇺🇸NIH · United States
Funds pilot work that is both necessary and sufficient to plan a later phase II, III or IV trial — with no further studies needed in between.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
🇺🇸NIH · United States
Funds an investigator's own phase I trial in heart, lung, blood or sleep disease — with every regulatory approval already in hand at award.
NOURISH: Autoimmunity Digital Health Challenge
🇺🇸OADR-ORWH · United States
Awards up to $650,000 across three phases for digital tools tracking autoimmune nutrition.
Prevention and Intervention Approaches for FASD (R34)
🇺🇸NIAAA · United States
Supports FASD prevention and intervention planning studies to establish feasibility and practical research direction.
Title X Family Planning Services Grants
🇺🇸HHS · United States
Supports family planning service providers across United States jurisdictions with grants that strengthen sexual health prevention, testing, counseling, and care.
TTAC Proof of Concept Program
🇺🇸LaunchTN · United States
Offers early-stage Tennessee innovators proof-of-concept support to de-risk and validate commercialization ideas.
BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS
🇺🇸NIH · United States
Funds a novel recording or modulation technology for the human central nervous system from proof of concept up to readiness for first-in-human studies.
Preclinical Proof of Concept for Novel Recording/Modulation Technologies in Human CNS
🇺🇸BRAIN Initiative · United States
Funds preclinical testing for novel neural recording and modulation technologies before clinical transition.
Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge
🇺🇸NIH · United States
Awards up to $13.1 million across three phases to US-based teams developing novel technologies that target RNA to treat human disease.
TRDNT Challenge Phase II: Prototype Development and Use Case Demonstration
🇺🇸NIH · United States
Pays up to $120,000 per Interim Milestone winner and up to $320,000 per Final Submission winner to US-based researchers, startups and institutions that build a working prototype technology able to target endogenous RNA in human disease.
NIDDK Priority HIV/AIDS Research R01
🇺🇸NIDDK · United States
Funds NIDDK-led research studying HIV and AIDS comorbidities across metabolic, kidney, and digestive disease.
NCATS Clinical Trial Readiness for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies generating natural history data, biomarkers, and outcome measures needed to design clinical trials for rare diseases.
SEED Research Program
🇺🇸UW Entrepreneurship Hub + WiSys · United States
Funds UW Madison spin-out research teams to advance commercialization through faculty-led projects.
Parkinson's Foundation Stanley Fahn Junior Faculty Award
🇺🇸Parkinson's Foundation · United States
Funds early-career Parkinson's disease researchers at United States and Canada institutions through independent investigator support.
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3)
🇺🇸NIH · United States
Funds the implementation of a clinical trial in arthritis, musculoskeletal or skin disease as a phased cooperative agreement with the institute.
NCATS STTR Phase I
🇺🇸NCATS · United States
Funds U.S. small businesses and their nonprofit research partners to conduct feasibility studies on translational science innovations toward commercialization.
NCATS STTR Phase II
🇺🇸NCATS · United States
Funds U.S. small businesses and their nonprofit research partners to continue and expand translational R&D begun in STTR Phase I toward a commercial product.
NIMHD Parent SBIR Grant
🇺🇸NIMHD · United States
Funds United States small businesses developing health-disparities technologies through NIH SBIR grants.
NIMHD Parent STTR Grant
🇺🇸NIMHD · United States
Funds United States small businesses partnering with nonprofit research institutions on health-disparities technologies.
NCATS SBIR Phase I
🇺🇸NCATS · United States
Supports small businesses testing translational science tools and technologies through early feasibility and commercialization groundwork.
NCATS SBIR Phase II
🇺🇸NCATS · United States
Backs small businesses scaling proven translational findings into applied solutions and early market readiness.
NCI SBIR/STTR Omnibus (Next Receipt 5)
🇺🇸NCI · United States
Supports small businesses developing cancer technologies through national NIH collaboration pathways.
NEI SBIR Phase I — Feasibility
🇺🇸NEI · United States
Supports United States. small businesses testing vision concepts through feasibility-focused grants.
NEI SBIR Phase II — R&D
🇺🇸NEI · United States
Supports United States. small businesses scaling vision concepts into full development pathways.